Tissue-engineered airway: A regenerative solution

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 1, 2012, Pages 81-93

  Jungebluth, P ^a   Moll, G ^a   Baiguera, S ^a   MacChiarini, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH FACTOR; MOLECULAR SCAFFOLD; TISSUE SCAFFOLD;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL MOTILITY; CELL THERAPY; HUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TRACHEA; TRACHEA RECONSTRUCTION; WOUND HEALING;

ANIMALS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; POLYMERS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRACHEA;

EID: 84055164238     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.270     Document Type: Review

References (75)

1. Grillo, H.C. Tracheal replacement: a critical review. Ann. Thorac. Surg. 73, 1995-2004 (2002). (Pubitemid 34596770)
2. Propst, E.J., Prager, J.D., Meinzen-Derr, J., Clark, S.L., Cotton, R.T. & Rutter, M.J. Pediatric tracheal reconstruction using cadaveric homograft. Arch. Otolaryngol. Head Neck Surg. 137, 583-590 (2011).
3. Baiguera, S. & Macchiarini, P. Trachea. In: Regenerative Medicine-From Protocol to Patient 1st edn (ed. Steinhoff, G.), 691-711 (Springer, London, 2011).
4. A tala, A., Bauer, S.B., Soker, S., Yoo, J.J. & Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241-1246 (2006).
5. Pham, C., Greenwood, J., Cleland, H., Woodruff, P. & Maddern, G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 33, 946-957 (2007). (Pubitemid 350051194)
6. Macchiarini, P. et al. Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023-2030 (2008).
7. Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920-926 (1993). (Pubitemid 23209960)
8. Kucera, K.A., Doss, A.E., Dunn, S.S., Clemson, L.A. & Zwischenberger, J.B. Tracheal replacements: part 1. ASAIO J. 53, 497-505 (2007). (Pubitemid 47220796)
9. Bader, A. & Macchiarini, P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J. Cell. Mol. Med. 14, 1877-1889 (2010).
10. Jungebluth, P. et al. Tracheobronchial transplantation using a stem cellseeded bioartificial nanocomposite. Lancet. (2011) (in press).
11. Ochs, M. & Weibel, E.R. Functional design of the human lung for gas exchange. In Fishman's Pulmonary Diseases and Disorders 4th edn. (eds. Fishman, A.P., Elias, J.A., Fishman, J.A., Grippi, M.A., Senior, R.M. & Pack, A.I.) 23-69 (McGraw-Hill Professional, Columbus, OH, 2008).
12. Beigel, A., Steffens-Knutzen, R., M-ler, B., Schumacher, U. & Stein, H. Tracheal transplantation. III. Demonstration of transplantation antigens on the tracheal mucosa of inbred rat strains. Arch. Otorhinolaryngol. 241, 1-8 (1984). (Pubitemid 15211224)
13. Kalb, T.H., Chuang, M.T., Marom, Z. & Mayer, L. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 4, 320-329 (1991).
14. Okubo, T., Knoepfler, P.S., Eisenman, R.N. & Hogan, B.L. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 132, 1363-1374 (2005). (Pubitemid 40528795)
15. Cardoso, W.V. & L-J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 133, 1611-1624 (2006). (Pubitemid 43810969)
16. Nehrer, S., Spector, M. & Minas, T. Histologic analysis of tissue after failed cartilage repair procedures. Clin. Orthop. Relat. Res. 365, 149-162 (1999). (Pubitemid 29382272)
17. Walles, T., Giere, B., Macchiarini, P. & Mertsching, H. Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering. Ann. Thorac. Surg. 78, 444-8; discussion 448 (2004). (Pubitemid 38980749)
18. Schmidt, C.E. & Baier, J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21, 2215-2231 (2000).
19. Rosso, F., Giordano, A., Barbarisi, M. & Barbarisi, A. From cell-ECM interactions to tissue engineering. J. Cell. Physiol. 199, 174-180 (2004). (Pubitemid 38436743)
20. Kim, D.Y. et al. Tissue-engineered allograft tracheal cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Laryngoscope 120, 30-38 (2010).
21. Gilbert, T.W., Sellaro, T.L. & Badylak, S.F. Decellularization of tissues and organs. Biomaterials 27, 3675-3683 (2006).
22. Sellaro, T.L., Ravindra, A.K., Stolz, D.B. & Badylak, S.F. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 13, 2301-2310 (2007). (Pubitemid 47404445)
23. Ott, H.C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213-221 (2008). (Pubitemid 351214548)
24. Badylak, S.F., Freytes, D.O. & Gilbert, T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 5, 1-13 (2009).
25. Hoshiba, T., Lu, H., Kawazoe, N. & Chen, G. Decellularized matrices for tissue engineering. Expert Opin. Biol. Ther. 10, 1717-1728 (2010).
26. Crapo, P.M., Gilbert, T.W. & Badylak, S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233-3243 (2011).
27. Meezan, E., Hjelle, J.T., Brendel, K. & Carlson, E.C. A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci. 17, 1721-1732 (1975).
28. Baiguera, S., Damasceno, K.L. & Macchiarini, P. Detergent-enzymatic method for bioengineering human airways. In Organ Perfusion and Culture Methodology. Methods in Bioengineering (eds. Lee, C. & Uygun, K.) (Artech House, Boston, MA, 2010).
29. Baiguera, S. et al. Tissue engineered human tracheas for in vivo implantation. Biomaterials 31, 8931-8938 (2010).
30. Macchiarini, P., Walles, T., Biancosino, C. & Mertsching, H. First human transplantation of a bioengineered airway tissue. J. Thorac. Cardiovasc. Surg. 128, 638-641 (2004). (Pubitemid 39278409)
31. Wurtz, A. et al. Surgical technique and results of tracheal and carinal replacement with aortic allografts for salivary gland-type carcinoma. J. Thorac. Cardiovasc. Surg. 140, 387-393.e2 (2010).
32. Go, T. et al. Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J. Thorac. Cardiovasc. Surg. 139, 437-443 (2010).
33. Seguin, A. et al. Tracheal replacement with cryopreserved, decellularized or glutaraldehyde-treated aortic allografts. Ann. Thorac. Surg. 87 (3), 861-867 (2009).
34. Tada, Y. et al. Regeneration of tracheal epithelium utilizing a novel bipotential collagen scaffold. Ann. Otol. Rhinol. Laryngol. 117, 359-365 (2008).
35. Y anagi, M. et al. Experimental study of bioactive polyurethane sponge as an artificial trachea. ASAIO J. 40, M412-M418 (1994).
36. Grimmer, J.F. et al. Tracheal reconstruction using tissue-engineered cartilage. Arch. Otolaryngol. Head Neck Surg. 130, 1191-1196 (2004). (Pubitemid 39371965)
37. Wu, W., Cheng, X., Zhao, Y., Chen, F., Feng, X. & Mao, T. Tissue engineering of trachea-like cartilage grafts by using chondrocyte macroaggregate: experimental study in rabbits. Artif. Organs 31, 826-834 (2007). (Pubitemid 350131993)
38. Weidenbecher, M., Tucker, H.M., Awadallah, A. & Dennis, J.E. Fabrication of a neotrachea using engineered cartilage. Laryngoscope 118, 593-598 (2008). (Pubitemid 351496772)
39. Tani, G., Usui, N., Kamiyama, M., Oue, T. & Fukuzawa, M. In vitro construction of scaffold-free cylindrical cartilage using cell sheet-based tissue engineering. Pediatr. Surg. Int. 26, 179-185 (2010).
40. Lutolf, M.P. & Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55 (2005). (Pubitemid 41724624)
41. Galili, U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfus. Apher. Sci. 35, 45-58 (2006). (Pubitemid 44354321)
42. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
43. Zhao, T., Zhang, Z.N., Rong, Z. & Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 (2011).
44. A postolou, E. & Hochedlinger, K. Stem cells: iPS cells under attack. Nature 474, 165-166 (2011).
45. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
46. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O. & Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331, 889-895 (1994). (Pubitemid 24299869)
47. Knutsen, G. et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am. 89, 2105-2112 (2007). (Pubitemid 47606154)
48. Pittenger, M.F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999). (Pubitemid 29282067)
49. Singer, N.G. & Caplan, A.I. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457-478 (2011).
50. Bilodeau, K. & Mantovani, D. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng. 12, 2367-2383 (2006). (Pubitemid 44734994)
51. A snaghi, M.A. et al. A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials 30, 5260-5269 (2009).
52. Petersen, T.H., Calle, E.A., Colehour, M.B. & Niklason, E. Bioreactor for long term culture of lung tissue. Cell Transplant. (2010); e-pub ahead of print.
53. Calle, E.A., Petersen, T.H. & Niklason, L.E. Procedure for lung engineering. J. Vis. Exp. 〈http://www.jove.com/video/2651/procedure-for- lung-engineering〉 (2011).
54. Ronzi?e, M.C., Perrier, E., Mallein-Gerin, F. & Freyria, A.M. Chondrogenic potential of bone marrow-and adipose tissue-derived adult human mesenchymal stem cells. Biomed. Mater. Eng. 20, 145-158 (2010).
55. Cals, F.L., Hellingman, C.A., Koevoet, W., Baatenburg de Jong, R.J. & van Osch, G.J. Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromalderived mesenchymal stem cells. J. Tissue Eng. Regen. Med. (2011) doi: 10.1002/term.399; e-pub ahead of print.
56. Puetzer, J.L., Petitte, J.N. & Loboa, E.G. Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Eng. Part B. Rev. 16, 435-444 (2010).
57. Martin, M.J., Muotri, A., Gage, F. & Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232 (2005). (Pubitemid 40321360)
58. Tonti, G.A. & Mannello, F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int. J. Dev. Biol. 52, 1023-1032 (2008).
59. Nilsson, B., Korsgren, O., Lambris, J.D. & Ekdahl, K.N. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol. 31, 32-38 (2010).
60. Mansilla, E. et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant. Proc. 38, 967-969 (2006).
61. Hannoush, E.J. et al. Impact of enhanced mobilization of bone marrow derived cells to site of injury. J. Trauma 71, 283-9; discussion 289 (2011).
62. Drukala, J.et al. Stem cells, including a population of very small embryoniclike stem cells, are mobilized into peripheral blood in patients after skin burn injury. Stem Cell Rev (2011); e-pub ahead of print.
63. Pitchford, S.C., Furze, R.C., Jones, C.P., Wengner, A.M. & Rankin, S.M. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4, 62-72 (2009).
64. Ehninger, A. & Trumpp, A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208, 421-428 (2011).
65. Rosenbeck, L.L., Srivastava, S. & Kiel, P.J. Peripheral blood stem cell mobilization tactics. Ann. Pharmacother. 44, 107-116 (2010).
66. Marquez-Curtis, L.A., Turner, A.R., Sridharan, S., Ratajczak, M.Z. & Janowska-Wieczorek, A. The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Rev. 7, 590-607 (2011).
67. Spaeth, E., Klopp, A., Dembinski, J., Andreeff, M. & Marini, F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15, 730-738 (2008). (Pubitemid 351627356)
68. Schraufstatter, I.U., Discipio, R.G., Zhao, M. & Khaldoyanidi, S.K. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J. Immunol. 182, 3827-3836 (2009).
69. Moll, G. et al. Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses. PLoS ONE 6, e21703 (2011).
70. Brines, M. & Cerami, A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264, 405-432 (2008).
71. Brines, M. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors. Blood Purif. 29, 86-92 (2010).
72. Patel, N.S. et al. A non-erythropoietic peptide that mimicks the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. Mol. Med. (2011) doi: 10.2119/molmed.2011. 00053.
73. Delaere, P., Vranckx, J., Verleden, G., De Leyn, P. & Van Raemdonck, D.; Leuven Tracheal Transplant Group. Tracheal allotransplantation after withdrawal of immunosuppressive therapy. N. Engl. J. Med. 362, 138-145 (2010).
74. Omori, K. et al. Clinical application of in situ tissue engineering using a scaffolding technique for reconstruction of the larynx and trachea. Ann. Otol. Rhinol. Laryngol. 117, 673-678 (2008).
75. Nakamura, T. et al. In situ tissue engineering for tracheal reconstruction using a luminar remodeling type of artificial trachea. J. Thorac. Cardiovasc. Surg. 138, 811-819 (2009).